All Stories

  1. Caffeic Acid Phenethyl Ester: A Potential Therapeutic Cancer Agent?
  2. Iron-related Biomarkers in the Diagnosis and Management of Iron Disorders
  3. Coenzyme Q10 for Enhancing Physical Activity and Extending the Human Life Cycle
  4. Perspectives on Iron Deficiency as a Cause of Human Disease in Global Public Health
  5. Early-Life Lead Exposure: Risks and Neurotoxic Consequences
  6. Berberine: Pharmacological Features in Health, Disease and Aging
  7. Metal Toxicity and Speciation: A Review
  8. A Comprehensive Review on Oxysterols and Related Diseases
  9. The essential metals for humans: A brief overview
  10. Medical Uses of Silver: History, Myths, and Scientific Evidence
  11. A new tripodal kojic acid derivative for iron sequestration: Synthesis, protonation, complex formation studies with Fe3+, Al3+, Cu2+ and Zn2+, and in vivo bioassays
  12. New strong extrafunctionalizable tris(3,4-HP) and bis(3,4-HP) metal sequestering agents: synthesis, solution and in vivo metal chelation
  13. Equilibrium studies of new bis-hydroxypyrone derivatives with Fe3+, Al3+, Cu2+ and Zn2+
  14. Mn(II) interaction with proteins responsible for ROS response and defense in DR
  15. Tungsten or Wolfram: Friend or Foe?
  16. The Intriguing Potential of “Minor” Noble Metals: Emerging Trends and New Applications
  17. Noble Metals in Pharmaceuticals: Applications and Limitations
  18. Looking at new ligands for chelation therapy
  19. A new tripodal-3-hydroxy-4-pyridinone for iron and aluminium sequestration: synthesis, complexation and in vivo studies
  20. para-Aminosalicylic acid in the treatment of manganese toxicity. Complexation of Mn2+ with 4-amino-2-hydroxybenzoic acid and its N-acetylated metabolite
  21. Ni(II) interaction with a peptide model of the human TLR4 ectodomain
  22. Interaction of a chelating agent, 5-hydroxy-2-(hydroxymethyl)pyridin-4(1 H )-one, with Al(III), Cu(II) and Zn(II) ions
  23. Complex formation equilibria of Cu2+ and Zn2+ with Irbesartan and Losartan
  24. Toxicity of Nanoparticles: Etiology and Mechanisms
  25. Joint 16th International Symposium on Trace Elements in Man and Animals (TEMA-16), 12th Conference of the International Society for Trace Element Research in Humans (ISTERH 2017) and 13th Conference of the Nordic Trace Element Society (NTES 2017)
  26. Chemical features of in use and in progress chelators for iron overload
  27. Silver coordination compounds: A new horizon in medicine
  28. Manganese binding to antioxidant peptides involved in extreme radiation resistance in Deinococcus radiodurans
  29. Competition between Cd(II) and other divalent transition metal ions during complex formation with amino acids, peptides, and chelating agents
  30. Fluoroquinolones: A micro-species equilibrium in the protonation of amphoteric compounds
  31. Coordination Environment of Cu(II) Ions Bound to N-Terminal Peptide Fragments of Angiogenin Protein
  32. Substituent effects on ionization constants as a predictive tool of coordinating ability
  33. Immune compatible cystine-functionalized superparamagnetic iron oxide nanoparticles as vascular contrast agents in ultrasonography
  34. Manganism and Parkinson's disease: Mn(ii) and Zn(ii) interaction with a 30-amino acid fragment
  35. Hydroxypyridinones with enhanced iron chelating properties. Synthesis, characterization and in vivo tests of 5-hydroxy-2-(hydroxymethyl)pyridine-4(1H)-one
  36. Zinc(II) and copper(II) complexes with hydroxypyrone iron chelators
  37. Tungsten-induced carcinogenesis in human bronchial epithelial cells
  38. An NMR study on the 6,6′-(2-(diethylamino)ethylazanediyl)bis(methylene)bis(5-hydroxy-2-hydroxymethyl-4H-pyran-4-one) interaction with AlIII and ZnII ions
  39. Noble metals in medicine: Latest advances
  40. Kill or cure: Misuse of chelation therapy for human diseases
  41. A new bis-3-hydroxy-4-pyrone as a potential therapeutic iron chelating agent. Effect of connecting and side chains on the complex structures and metal ion selectivity
  42. Nutritional Iron Deficiency: The Role of Oral Iron Supplementation
  43. Toxicity of Nanoparticles
  44. Ni(ii) binding to the 429–460 peptide fragment from human Toll like receptor (hTLR4): a crucial role for nickel-induced contact allergy?
  45. Interaction of Cu(II) and Ni(II) with Ypk9 Protein FragmentviaNMR Studies
  46. The Involvement of Amino Acid Side Chains in Shielding the Nickel Coordination Site: An NMR Study
  47. Nickel binding sites in histone proteins: Spectroscopic and structural characterization
  48. Interaction of divalent cations with peptide fragments from Parkinson's disease genes
  49. Manganese and cobalt binding in a multi-histidinic fragment
  50. Mn(ii) and Zn(ii) interactions with peptide fragments from Parkinson's disease genes
  51. NMR studies of zinc binding in a multi-histidinic peptide fragment
  52. Nickel binding to histone H4
  53. Metal-chelating properties of carvedilol: an antihypertensive drug with antioxidant activity
  54. Copper and nickel binding in multi-histidinic peptide fragments
  55. An NMR study on nickel binding sites in Cap43 protein fragments
  56. Copper(ii) binding to Cap43 protein fragments
  57. Paramagnetism-Based NMR Restraints Provide Maximum Allowed Probabilities for the Different Conformations of Partially Independent Protein Domains
  58. Multidimensional NMR spectroscopy for the study of histone H4–Ni(ii) interaction
  59. Nickel(II) binding to Cap43 protein fragments
  60. Experimentally exploring the conformational space sampled by domain reorientation in calmodulin
  61. The binding of Ni(ii) and Cu(ii) with the N-terminal tail of the histone H4